RedHill Biopharma Ltd. (RDHL)

2.17

-0.24 (-9.96%)

At close: Apr 28, 2025, 3:59 PM

2.19

0.69%

After-hours: Apr 28, 2025, 07:42 PM EDT

RedHill Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-8.27M	23.92M	-71.67M	-97.74M	-76.17M	-42.3M	-38.82M	-45.54M	-29.37M
Depreciation & Amortization	619K	1.99M	8.15M	18.15M	8.74M	1.21M	90K	81K	44K
Stock-Based Compensation	665K	1.65M	5.67M	10.21M	4.2M	3.03M	2.68M	2.23M	1.68M
Other Working Capital	3.37M	-50.44M	14.49M	10.04M	33.13M	-1.83M	2.45M	1M	711K
Other Non-Cash Items	-4.44M	-47.79M	20.65M	5.37M	6.03M	-347K	35K	-123K	94K
Deferred Income Tax	n/a	n/a	n/a	123K	195K	n/a	136K	-5.08M	-1.26M
Change in Working Capital	2.05M	-15.58M	8.01M	-1.15M	8.42M	-2.34M	1.42M	3.66M	553K
Operating Cash Flow	-9.37M	-35.82M	-29.18M	-65.05M	-48.58M	-40.75M	-34.46M	-44.77M	-28.26M
Capital Expenditures	-9K	-11K	-198K	-115K	-53.77M	-203K	-58K	-1.18M	-120K
Cash Acquisitions	n/a	n/a	n/a	8.03M	n/a	35K	35K	11.96M	-36.87M
Purchase of Investments	n/a	n/a	n/a	-8.5M	n/a	-4.33M	-6.98M	-34.92M	-12.25M
Sales Maturities Of Investments	n/a	14.96K	8.5M	475K	18.13M	9.69M	12.39M	17.52M	36.84M
Other Investing Acitivies	n/a	10.00	8.5M	-8.03M	-35.24M	-35K	-35K	-11.96M	36.87M
Investing Cash Flow	-9K	4K	8.3M	-8.14M	-35.65M	5.16M	5.35M	-18.58M	24.47M
Debt Repayment	-636K	n/a	-1.48M	-1.68M	76.45M	-796K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	790K	7.52M	-10.88M	-3.39M	-15.95M	5K	-139K	3.44M	263K
Financial Cash Flow	8.42M	21.44M	11.45M	73.46M	84.37M	35.51M	41.76M	25.65M	36.02M
Net Cash Flow	-952K	-14.4M	-9.51M	179K	272K	18K	12.55M	-37.33M	32.27M
Free Cash Flow	-9.38M	-35.83M	-29.38M	-65.16M	-102.35M	-40.95M	-34.52M	-45.95M	-28.38M